The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

The company's newer product, an RSV ( respiratory syncytial virus) vaccine, has also underperformed, contributing "minimal ...

Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its ...

Shares of Moderna tumbled Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year.

The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin.

We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, ...

The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, ...

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...